retatrutide and heart health Safety, Side Effects & Provider Use Retatrutide for weight loss: Study

Peptide receptor radionuclide therapy targeting the somatostatin receptor: basic principles, clinical applications and optimization strategies

Nonalcoholic steatohepatitis (NASH), the aggressive form of NAFLD, can progress to cirrhosis and hepatocellular cancer (HCC) and is rapidly becoming the leading cause for end-stage liver disease or liver transplantation [3]

We often consume way more than we realize

Most headaches on tirzepatide resolve within the first few weeks of a stable dose

They more often exhibit peripheral oedema, orthopnoea, a higher New York Heart Association (NYHA) functional class for HF and significantly reduced 6MWT distance

The ER is a central organelle for proinsulin folding, a capacity that is often overwhelmed in insulin-resistant states (Sharma et al., 2011)